Low- and middle-income countries (LMIC) currently experience low testing coverage in the face of increasing demand to meet the needs of millions of people living with HIV, TB, HPV, hepatitis and other diseases. Therefore, innovative solutions are urgently needed to enable a robust, efficiently utilised testing capacity, and a healthy and secure market with competitive supply.

ASLM is excited to host the diagnostic pricing database on behalf of the Integrated Diagnostics Consortium. Led by the Clinton Health Access Initiative, with funding from Unitaid, this pricing database initially focuses on automated molecular testing solutions offered to LMICs, to bring greater clarity and transparency to supplier pricing. The format of the pricing database is meant to facilitate a comparison of supplier pricing and offerings across crucial components of test procurement, including commodities, logistics, service and key product features. The pricing database, accessible below, will be updated biannually or when new information becomes available to reflect the latest changes in the market.

The pricing information below was last updated in May 2023. There is new pricing available that will be updated in the coming weeks.

Diagnostic Pricing 1

wdt_ID Company Platforms Corresponding assays Access pricing - Instrument purchased or placed Access pricing - Volume commitment Access pricing - Price per test (USD) Access pricing - Incoterm Access pricing - Price per instrument, if purchased (USD) Agreement specifications - Time commitment Agreement specifications - Eligible countries Laboratory - Reagents and proprietary consumables Laboratory - Invalid results due to instrument errors Laboratory - Non-proprietary consumables Laboratory - Instrument placement Laboratory - Service and maintenance (S&M) Laboratory - S&M fee per instrument (if not included in price) Supply chain for tests - Distributor and local agent fees Supply chain for tests - Packaging Supply chain for tests - Loading from warehouse Supply chain for tests - Pre-carriage Supply chain for tests - Export customs clearance Supply chain for tests - Handling at departure Supply chain for tests - Main transportation Supply chain for tests - Transportation insurance Supply chain for tests - Handling at arrival Supply chain for tests - Post-carriage Supply chain for tests - Duties and local taxes Supply chain for tests - Import customs clearance Supply chain for tests - Unloading at destination Additional resources and references
Company Platforms Corresponding assays

Diagnostic Pricing 2

wdt_ID Company Platforms Photo of platform Integrated kit/ separate reagents Batch controls Instrument portability Level of automation Max daily throughput inlcuding controls (Tests/8hr; 24hr) Sample loading Sample processing Time to first result (hrs)
Abbott

*Multiple RT-PCR modules independently process cartridges

** https://www.molecular.abbott/int/en/products/instrumentation/alinity-m-instrument 

***The analyzer performs any requested sample in any sequence

**** https://www.molecular.abbott/int/en/products/instrumentation/m2000-realtime-system 

Cepheid

***** Max daily throughput reported here is for Xpert MTB/RIF assay as is calculated assuming 15% prevalence though actual throughput may vary based on local prevalence. Throughput varies for other assays.

****** Time to result differs by test, ranging from 40 – 105 minutes for tests available through Cepheid’s Global Access Program. Information about the time-to-result for each test can be found on Cepheid’s website, linked.

Hologic

*******The analyzer performs any requested sample in any sequence

 

 

Supplier Contact Information

Cepheid: Rachel O’Shea, Vice President, Global Access (Email)
Abbott: Francesco Marinucci, Director, Global Market Access & Funding (Email)
Roche: Asif Ali, Project Manager Global Access Program (Email)
Hologic: Tiffany Clarke, Director, Global Health Strategy (Email)
Hologic: Jennifer Lim, Portfolio Manager, Global Health Strategy (Email)
MolBio: Sumit Mitra, President S&M, Global Markets (Email)

Additional Resources & References

All
1

All prices for Abbott, Cepheid and Roche are indicative; small variations are possible based on the individual components in any given order.

Abbott
2

Abbott mPima pricing: The exact price point within the range provided will depend on the combination of existing instruments (which were purchased) and new instruments (which will be placed), as well as whether the existing instruments are under warranty.

3

Instrument placement assumes utilizing in-country molecular infrastructure and placing additional equipment only if volumes justify doing so.

4

Other countries can be added based on instrument launch

5

Other countries can be added on an ad-hoc basis

6

Abbott is in the process of revising the volume tiers and establishing global base prices with committed volumes for HIV, HBV and HCV tests. Please confirm updates with supplier.

Cepheid
7

Applicable only to GX XVI platforms

8

MTB/RIF (GX4) is being discontinued

9

This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by the authorized laboratories; this product has been authorized only for the detection of nucleic acid from monkeypox virus or other non-variola orthopoxviruses, not for any other viruses or pathogens; and the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

12

Cepheid’s pricing for all GX assays indicated above is prepaid (payment made in full before goods are shipped) and when procured directly from Cepheid. Additional cost would be added when incoterm is different from EXW and/or when goods are procured through a local distributor.

13

Other incoterms are possible at additional cost, please contact Cepheid directly

14

Applicable only to GX XVI platforms

15

S&M would be included for all GX XVI platforms placed in the price per test

16

Cepheid’s pricing for all GX assays indicated above is prepaid (payment made in full before goods are shipped) and when procured directly from Cepheid. Additional cost would be added when incoterm is different from EXW and/or when goods are procured through a local distributor.

17

Each GX XVI placement requires an annual purchase of 10,000 tests (of any corresponding assay listed except SARS-CoV-2) spread across all GeneXpert systems in the participating country.

18

Specific incoterm to be decided based on negotiation

Hologic
19

Instrument placement assumes utilizing in-country molecular infrastructure and placing additional equipment only if volumes justify doing so

20

If the 30,000 test/instrument annual average cannot be met, Hologic has a separate pricing model that may be applicable for certain eligible countries

21

This is a ceiling price associated with the volume commitment outlined above; lower prices may be accessed on a country-by-country basis

22

Special all-inclusive pricing for Aptima HPV is enabled through a 1,000,000 annual test volume commitment under the Global Health Supply Chain – Procurement and Supply Management Project (GHSC-PSM).

Roche
23

Different prices may apply for special projects/grants, please contact Roche directly

24

MTB/ RIF-INH – The Roche Global Access Program pricing model encourages reflex RIF/INH testing as per WHO Guidance. price per test for every patient is $8.90 ($7.90 + $1.00 for RIF/INH reflex)

25

Different prices may apply for special projects/grants, please contact Roche directly

26

Instrument Surcharge (Reagent Rental) is determined by the total annual volumes of all tests (HIV, HPV, MTB and HCV/HBV, COVID-19) at the country level averaged across the entire footprint; for country specific details please contact Roche directly

27

Service Surcharge is determined by the total annual volumes of all tests (HIV, HPV, MTB and HCV/HBV, COVID-19) at the country level averaged across the entire footprint, for country specific details please contact Roche directly

28

Supply Chain Surcharge for Incoterms DAP is determined by country specific factors considering volatility around logistics costs, for country specific details please contact Roche directly

MolBio
29

20 Truenat MTB/RIF tests free with purchase of 100 Truenat MTB/MTBPLUS tests purchased. In the future users will be able to select a combination of MTB/RIF and INH

30

UNO workstation = UNODx + TrueprepAUTO + Printer + Pipette + Accessories

31

DUO workstation = DUODx + TrueprepAUTO + Printer + Pipette + Accessories

32

QUATTRO workstation = QUATTRO + 2 units TrueprepAUTO + Printer + Pipette + Accessories

Molecular Diagnostic Pricing Database Data

Below is a tabled sheet of the data. The chart is defaulted to show the first ten entries, but you can use the provided dropdown and paging buttons to view more entries.

ASLM is not responsible for the integrity of the data included herein after data files have been exported.

Use the search bar to the right to search for specific key terms.
Export Full Data

Diagnostic Pricing 1

wdt_ID Company Platforms Corresponding assays Access pricing - Instrument purchased or placed Access pricing - Volume commitment Access pricing - Price per test (USD) Access pricing - Incoterm Access pricing - Price per instrument, if purchased (USD) Agreement specifications - Time commitment Agreement specifications - Eligible countries Laboratory - Reagents and proprietary consumables Laboratory - Invalid results due to instrument errors Laboratory - Non-proprietary consumables Laboratory - Instrument placement Laboratory - Service and maintenance (S&M) Laboratory - S&M fee per instrument (if not included in price) Supply chain for tests - Distributor and local agent fees Supply chain for tests - Packaging Supply chain for tests - Loading from warehouse Supply chain for tests - Pre-carriage Supply chain for tests - Export customs clearance Supply chain for tests - Handling at departure Supply chain for tests - Main transportation Supply chain for tests - Transportation insurance Supply chain for tests - Handling at arrival Supply chain for tests - Post-carriage Supply chain for tests - Duties and local taxes Supply chain for tests - Import customs clearance Supply chain for tests - Unloading at destination Additional resources and references
Company Platforms Corresponding assays

Molecular Diagnostic Pricing Database Data

Below is a tabled sheet of the data. The chart is defaulted to show the first ten entries, but you can use the provided dropdown and paging buttons to view more entries.

ASLM is not responsible for the integrity of the data included herein after data files have been exported.

Use the search bar to the right to search for specific key terms.
Export Full Data

Diagnostic Pricing 2

wdt_ID Company Platforms Photo of platform Integrated kit/ separate reagents Batch controls Instrument portability Level of automation Max daily throughput inlcuding controls (Tests/8hr; 24hr) Sample loading Sample processing Time to first result (hrs)
Abbott

*Multiple RT-PCR modules independently process cartridges

** https://www.molecular.abbott/int/en/products/instrumentation/alinity-m-instrument 

***The analyzer performs any requested sample in any sequence

**** https://www.molecular.abbott/int/en/products/instrumentation/m2000-realtime-system 

Cepheid

***** Max daily throughput reported here is for Xpert MTB/RIF assay as is calculated assuming 15% prevalence though actual throughput may vary based on local prevalence. Throughput varies for other assays.

****** Time to result differs by test, ranging from 40 – 105 minutes for tests available through Cepheid’s Global Access Program. Information about the time-to-result for each test can be found on Cepheid’s website, linked.

Hologic

*******The analyzer performs any requested sample in any sequence